Back to search
FDAFDA · Food and drugs·Recall number D-0689-2016

papaverine prostaglandin 30 mg/20 mcg/mL, 10 mL unit size; refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705

Published February 24, 2016 · Recall initiated: January 15, 2016

Summary

FDA records drug Class II recall D-0689-2016, published February 24, 2016 and initiated January 15, 2016. Recalling firm: Abbott's Compounding Pharmacy, Inc.; Status: Terminated; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott's Compounding Pharmacy, Inc.
Distributor
CA
Lot
All lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was papaverine prostaglandin 30 mg/20 mcg/mL, 10 mL unit size; refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705 recalled?

Yes. FDA published recall D-0689-2016 on February 24, 2016. Reported hazard: Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release